Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes.

Immunity, inflammation and disease - 1 Dec 2023

Temiz Karadağ Duygu, Komac Andac, Erez Yesim, Birlik Ahmet Merih, Sari Alper, Akdoğan Ali, Farisogullari Bayram, Kimyon Gezmiş, Koc Emrah, Arslan Didem, Karatas Ahmet, Koca Suleyman Serdar, Kasifoglu Nilgün, Yazici Ayten, Hayran Kadir Mutlu, Cefle Ayse

Abstract excerpt

BACKGROUND/AIM: To investigate the frequency and clinical relevance of an extended autoantibody profile in patients with systemic sclerosis (SSc). MATERIALS AND METHODS: In this cross-sectional study, serum from 100 consecutive patients was subjected to indirect immunofluorescence (IIF) (HEp-20-10/primate liver mosaic) and Systemic Sclerosis Profile by EUROIMMUN to evaluate anti-nuclear antibodies (ANA) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Scleroderma, Systemic

Source

Open in PubMed Open full text

Identifiers

PMID: 38134320
DOI: 10.1002/iid3.1089
PMCID: PMC10716734

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes.PMID 38134320Read ↗

Extended Autoantibody Panel in Turkish Patients with Early-Stage Systemic Sclerosis: Co-expressions and Their Influences on Clinical PhenotypesSemantic proximity Read ↗

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.Semantic proximity Read ↗

Clinical distinctions of anti-topoisomerase positive limited cutaneous systemic sclerosis in early disease: results from the early Systemic sclerOsis Longitudinal Assessment Registry from Turkey.Semantic proximity Read ↗

Disease-related autoantibody profile in patients with systemic sclerosisSemantic proximity Read ↗

Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosisSemantic proximity Read ↗

Comprehensive Autoantibody Profiles in Systemic Sclerosis: Clinical Cluster AnalysisSemantic proximity Read ↗

Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosisSemantic proximity Read ↗

Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement.Semantic proximity Read ↗

Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.Semantic proximity Read ↗

HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients.Semantic proximity Read ↗

Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.Semantic proximity Read ↗

HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.